Skip to content
The People's CodeSearch
Menu

Changes to the Code

H.R. 1492 · To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program. ·

In committee · step 2 of 5

Sections are cited like “7 U.S.C. § 2012”: 7 of the , 2012.

42 U.S.C. § 1320f–1 Selection of negotiation-eligible drugs as selected drugs

+1 −1Shown
More for 42 U.S.C. § 1320f–1
Read § 1320f–1Only this section
1 change the bill asks for here, 1 carried out
  1. Carried out:

    Section 1192(e)(1)(A)(ii) of the Social Security Act (42 U.S.C. 1320f–1(e)(1)(A)(ii)) is amended by striking 7 years and inserting 11 years.

§ 1320f–1(e)(1)In general(A)–(B)

Start of § 1320f–1 to (e)(1)(A) unchanged

WhereMarkThe Code nowMarkAs the bill would leave it
(A)(i)(i) (i)
that is approved under section 355(c) of title 21 and is marketed pursuant to such approval;that is approved under section 355(c) of title 21 and is marketed pursuant to such approval;
(A)(ii)(ii) (ii)
for which, as of the selected drug publication date with respect to such initial price applicability year, at least [struck: 7] years will have elapsed since the date of such approval; andfor which, as of the selected drug publication date with respect to such initial price applicability year, at least [inserted: 11] years will have elapsed since the date of such approval; and
(A)(iii)(iii) (iii)
that is not the listed drug for any drug that is approved and marketed under section 355(j) of such title.that is not the listed drug for any drug that is approved and marketed under section 355(j) of such title.
(B)(B) Biological products(B) Biological products
A biological product—A biological product—

Rest of § 1320f–1 unchanged

Step through the changes